{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:28:12Z","timestamp":1790483292479,"version":"4.1.0"},"reference-count":46,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1469,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1360-0443.2011.03515.x","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T15:52:18Z","timestamp":1306338738000},"page":"1978-1988","source":"Crossref","is-referenced-by-count":268,"title":["The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence"],"prefix":"10.1111","volume":"106","author":[{"given":"Katy M. E.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vickerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Craine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Palmateer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avril","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,24]]},"reference":[{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00042560-199802001-00003","article-title":"The importance of preventing hepatitis C virus infection among injection drug users in the United States","volume":"18","author":"Alter","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.20836","article-title":"Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland","volume":"42","author":"Hutchinson","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/biostatistics\/kxn004","article-title":"Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit","volume":"9","author":"Sweeting","year":"2008","journal-title":"Biostatistics"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0962280208094691","article-title":"An evidence synthesis approach to estimating hepatitis C prevalence in England and Wales","volume":"18","author":"De Angelis","year":"2009","journal-title":"Stat Methods Med Res"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2010.08.029","article-title":"Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modelling analysis of its prevention utility","volume":"54","author":"Martin","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB6|cit6","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckr083","article-title":"Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis","author":"Harris","year":"2011","journal-title":"Eur J Public Health"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB7|cit7","volume-title":"The Primary Prevention of Hepatitis C Among Infecting Drug Users","author":"Advisory Council on Misuse of Drugs","year":"2009"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2893.2004.00517.x","article-title":"Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection","volume":"11","author":"Sypsa","year":"2004","journal-title":"J Viral Hepatol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2893.2007.00851.x","article-title":"The burden of hepatitis C in England","volume":"14","author":"Sweeting","year":"2007","journal-title":"J Viral Hepatol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/aje\/kwn237","article-title":"Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place","volume":"168","author":"Hagan","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2893.2007.00855.x","article-title":"Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004","volume":"14","author":"Hickman","year":"2007","journal-title":"J Viral Hepatol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/aje\/kwp141","article-title":"Hepatitis C infection among injecting drug users in England and Wales (1992-2006): there and back again?","volume":"170","author":"Sweeting","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0950268802006945","article-title":"Prevalence of hepatitis C among injectors in Scotland 1989-2000: declining trends among young injectors halt in the late 1990s","volume":"128","author":"Hutchinson","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB14|cit14","volume-title":"Preventing HIV Infection Among Injecting Drug Users in High-Risk Countries: An Assessment of the Evidence","author":"Committee on the Prevention of HIV Infection Among Injecting Drug Users in High-Risk Countries","year":"2007"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1360-0443.2009.02888.x","article-title":"Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews","volume":"105","author":"Palmateer","year":"2010","journal-title":"Addiction"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB16|cit16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004145.pub3","article-title":"Substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0140-6736(96)11380-5","article-title":"Effectiveness of needle-exchange programmes for prevention of HIV infection","volume":"349","author":"Hurley","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.aids.0000192066.86410.8c","article-title":"Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001","volume":"19","author":"Des Jarlais","year":"2005","journal-title":"AIDS"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ije\/dyg102","article-title":"The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users","volume":"32","author":"Murray","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1017\/S095026880900212X","article-title":"Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size","volume":"137","author":"Craine","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2893.2010.01297.x","article-title":"Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots","volume":"18","author":"Hope","year":"2011","journal-title":"J Viral Hepatol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB24|cit24","unstructured":"University of the West of Scotland, Health Protection Scotland, West of Scotland Specialist Virology Centre The Needle Exchange Surveillance Initiative (NESI): prevalence of HCV and injecting risk behaviours among injecting drug users attending needle exchanges in Scotland, 2008\/2009 2010"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.38286.841227.7C","article-title":"Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study","volume":"330","author":"Judd","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1525\/sp.1997.44.2.03x0221m","article-title":"Respondent-driven sampling: a new approach to the study of hidden populations","volume":"44","author":"Heckathorn","year":"1997","journal-title":"Soc Problems"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"c4851","DOI":"10.1136\/bmj.c4851","article-title":"The impact of supervised methadone consumption on opiate overdose deaths in England and Scotland: analysis using the OD4 Index","volume":"341","author":"Strang","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1360-0443.2006.01741.x","article-title":"Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users","volume":"102","author":"Bluthenthal","year":"2007","journal-title":"Addiction"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB29|cit29","first-page":"136","article-title":"When 100% really isn't 100%: improving the accuracy of small-sample estimates of completion rates","volume":"1","author":"Lewis","year":"2010","journal-title":"J Usability Stud"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2307\/2276774","article-title":"Probable inference, the law of succession, and statistical inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Stat Assoc"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2893.2005.00643.x","article-title":"Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis","volume":"12","author":"Judd","year":"2005","journal-title":"J Viral Hepatol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB33|cit33","volume-title":"Return on Investment in Needle and Syringe Programs in Australia","author":"Drummond","year":"2002"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Stat Med"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1086\/649783","article-title":"Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities","volume":"201","author":"Hagan","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/ije\/dyl276","article-title":"Modelling the impact on hepatitis C transmission of reducing syringe sharing: London case study","volume":"36","author":"Vickerman","year":"2007","journal-title":"Int J Epidemiol"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"c3172","DOI":"10.1136\/bmj.c3172","article-title":"Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment","volume":"341","author":"Kimber","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/0962280208094704","article-title":"Estimating the prevalence of ex-injecting drug use in the population","volume":"18","author":"Sweeting","year":"2009","journal-title":"Stat Methods Med Res"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.drugpo.2007.01.016","article-title":"HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection","volume":"18","author":"Hagan","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB41|cit41","unstructured":"National Institute for Health and Clinical Excellence (NICE) Needle and syringe programmes: providing people who inject drugs with injecting equipment 2008 NICE http:\/\/www.nice.org.uk\/PH18 http:\/\/www.webcitation.org\/60paZ9c4f"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB42|cit42","unstructured":"World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC), Joint United Nations Programme on HIV\/AIDS (UNAIDS) Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users WHO 2008"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB43|cit43","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Harm reduction: evidence, impacts and challenges EMCDDA 2010"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB44|cit44","unstructured":"Commonwealth of Australia The Third National Hepatitis C Strategy 2010-2013 2010"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/infdis\/jiq111","article-title":"Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity","volume":"203","author":"Grebely","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1360-0443.2011.03515.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.puhe.2008.01.014","article-title":"Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis","volume":"122","author":"Xia","year":"2008","journal-title":"Public Health"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2011.03515.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1360-0443.2011.03515.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T16:58:41Z","timestamp":1625417921000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2011.03515.x"}},"subtitle":["Impact of NSP and OST on HCV"],"short-title":[],"issued":{"date-parts":[[2011,8,24]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03515.x","relation":{},"ISSN":["0965-2140"],"issn-type":[{"value":"0965-2140","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,24]]}}}